Materials and Methods
Young adult male Sprague-Dawley rats (body weight 250 to 300 g) were housed in a temperature-and light-controlled room (lights on at 06 : 00 and off at 18 : 00) and supplied with standard laboratory chow and water ad libitum. All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee of Showa University. The primary antiserum was affinity-purified goat polyclonal antibody raised against peptide corresponding to amino acids 877-894, mapping at the carboxyterminus of the mouse leptin receptor (Santa-Cruz Biotechnology, Santa-Cruz, CA, USA). With this antiserum, immunoblot analysis yielded a strong single band at 120 kDa in all brain regions 14). In addition, when the antiserum used in the present study was tested using SKN-ML, HeLa, A431 and MCF-7 whole cell lysates, a strong band for leptin receptor was observed at 120 kDa (personal communication from Santa-Cruz Biotechnology, 1997). Thus, immunoblot analysis indicated that the antiserum reacted specifically only with leptin receptor 14) . To verify the specificity of the staining, the sections were incubated with (1) non-immune serum instead of the primary antiserum, (2) the primary antisera without the second antiserum, or (3) the primary antisera that had been preabsorbed with the antigen (50 p g of peptide, Santa-Cruz Biotechnology in 1 ml of antiserum at the working dilution). molecular mass of leptin receptor in the brain 5). Immunohistochemical staining with the antiserum yielded intense staining in the hypothalamus. Many neuronal cell bodies and dendritic processes showed LR-LI in many brain regions. The results showed extensive distribution of LR-LI in the hypothalamus with positively stained cells present in the arcuate nucleus, ventromedial nucleus, parvo-and magno-cellular parts of the paraventricular nucleus, supraoptic nucleus, periventricular nucleus and lateral hypothalamic area (Fig. 1) .
Using an immunoperoxidase method, many neuronal cell bodies and dendritic processes stained positive in the arcuate nucleus ( Fig. 2A, B) .
At the ultrastructural level, immunoreactive products representing LR-LI could be observed in the cytoplasm in the vicinity of rough endoplasmic reticulum (rER).
As expected for an antibody directed against a cytoplasmic epitope, labeling was localized to the cytoplasmic face of the plasma membrane, rER cisternae, vicinity of the plasma membranes and in the cytoplasmic matrices (Fig. 3, 4) . Interestingly, intense labeling of the Golgi apparatus was observed (Fig. 4) . Immunoreaction products were not localized with either pre-or post-synaptic membranes at axo-somatic and axo-dendritic synapses. The hypothalamic arcuate nucleus is the main target of circulating leptin. When 125I -leptin has been injected intravenously, leptin is transported intact from blood to brain by a saturable system 17) . Autoradiographic data have shown that radiolabeled leptin is specifically taken-up at the choroid plexus, arcuate nucleus of the hypothalamus, and median eminence after intravenous infusion 17). The arcuate nucleus is a primary site of the satiety effect of leptin 7). There is evidence that the ventral part of the arcuate nucleus lacks a blood-brain barrier (BBB) 18) . These studies suggest that leptin secreted in adipocytes is transported to the arcuate nucleus via the general circulation and acts on leptin receptors in the arcuate nucleus which lacks the BBB. Immunohistochemical studies have shown that the arcuate nucleus contains numerous Neuropeptide Y (NPY) -containing neurons and fibers8, 19) NPY is a peptide involved in stimulation of food intake and energy balance3,12, 20, 21) Leptin is shown to inhibit NPY synthesis and release20) and leptin inhibits NPY gene expression through a specific action in the arcuate nucleus4) . Leptin receptor-and NPY-like immunoreactivity are expressed in the same cells in the arcuate nucleus 13) . Our data and other studies strongly suggest that leptin receptor is expressed in NPY neurons, and that leptin inhibits food intake by inhibiting NPY neurons through its specific receptors. LR-LI is present in NPY-, adrenocorticotropic hormone-, proopiomelanocortin-, galanin-and growth hormone-releasing hormone-containing neurons in the arcuate nucleus13).
We have shown co-localization of leptin receptor-and tyrosine-hydroxylase-like immunoreactivity in the same arcuate neurons (data not shown). LR-LI is also demonstrated in vasopressin-and oxytocin-containing neurons in the supraoptic and paraventricular nuclei 13). 
